- Report
- May 2026
- 100 Pages
Global
From €5331EUR$5,950USD£4,567GBP
- Report
- October 2025
- 120 Pages
Global
From €5331EUR$5,950USD£4,567GBP
- Report
- January 2026
- 184 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- April 2026
- 138 Pages
Global
From €2687EUR$2,999USD£2,302GBP
€3583EUR$3,999USD£3,069GBP
- Report
- April 2026
- 137 Pages
Global
From €2687EUR$2,999USD£2,302GBP
€3583EUR$3,999USD£3,069GBP
- Report
- April 2026
- 149 Pages
Global
From €2687EUR$2,999USD£2,302GBP
€3583EUR$3,999USD£3,069GBP
- Report
- August 2026
- 370 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- August 2026
- 285 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- January 2026
- 282 Pages
Global
From €2240EUR$2,500USD£1,919GBP
- Report
- January 2026
- 292 Pages
Global
From €2240EUR$2,500USD£1,919GBP
- Report
- January 2026
- 198 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- January 2026
- 185 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- January 2026
- 182 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- July 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- May 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- May 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- May 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- May 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- May 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more